Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – Genital ulcers are common in HIV-infected women when antiretroviral therapy (ART) begins, particularly when CD4 counts are low or when women have had…
NEW YORK (Reuters Health) – The Advisory Committee on Immunization Practices (ACIP) has issued a “permissive recommendation” for the quadrivalent human papillomavirus vaccine (HPV4) in males, to protect…
NEW YORK (Reuters Health) – As a mass screening tool for diabetes and pre-diabetes in China, the fasting capillary blood glucose (FCG) test performs better than the hemoglobin…
An interview with Adam Bosworth, founder of Keas. Keas is a web-based patient resource whose mission is to help patients understand what their health data means and how…
NEW YORK (Reuters Health) – Old age has a greater impact on abdominal surgery outcomes than previously reported, according to two papers in the December Archives of Surgery.…
NEW YORK (Reuters Health) – In patients with chronic total coronary occlusions, drug-eluting stents (DES) have better long-term outcomes than bare metal stents, according to a paper from…
Donnica Moore, MD, President, Sapphire Women’s Health Group, discusses Chronic Fatigue Syndrome or CFS, its definition and symptoms. CFS is a chronic, debilitating neuroimmune disease that not only…
NEW YORK (Reuters Health) – Patients treated with high-dose recombinant activated factor VII (rFVIIa) for spontaneous intracerebral hemorrhage face a “small increased risk of what are usually minor…
NEW YORK (Reuters Health) – The benefits of statins are variable and depend on the agent being taken, a meta-analysis has shown. Pooled data from 10 randomized trials…
NEW YORK (Reuters Health) – Consistent with their ability to block platelet aggregation, selective serotonin reuptake inhibitors (SSRIs) appear to increase the risk of serious upper gastrointestinal (GI)…
